Postnatal contraception discontinuation: different methods, same problem

摘要: Following publication of our trial on the effects postnatal depot medroxyprogesterone acetate (DMPA) compared with copper intrauterine device (IUD) depression in this journal July 2016,1 we have sought to evaluate contraceptive discontinuation study sample. Postnatal contraception is promoted as part WHO strategy reduce unmet need for family planning low- and middle-income countries (LMICs) preventable maternal child mortality.2 However, little known about rates associated use these settings. From trial, 75 242 participants were contactable two or more years after randomisation 54 consented a follow-up interview, which was conducted by Masters student from University Fort Hare (NDY). Twenty-three women had received DMPA 31 an IUD. In IUD arms, respectively, 48% (11/23) 42% …